Fundraising Fox
🦊/Companies
Sign in

Aerin Medical

Mountain View, US · Founded 2011 · Delaware corporation · 148 employees on LinkedIn · 6 known investors

Find your way into Aerin Medical

570 people in our graph share verified history with the Aerin Medical team — schools, employers, funds. One of them is your warm intro.

Akshat Goenkaunlockedknows Scott Wolf, MD · together at Y Combinator (overlapped)
×11knows the team · via Y Combinator

Aerin Medical develops non-invasive radiofrequency treatment systems for chronic nasal conditions, offering the VivAer stylus for nasal airway obstruction and RhinAer stylus for chronic rhinitis. The treatments are performed in doctor's offices and operating rooms using a touch-screen console that delivers temperature-controlled radiofrequency therapy.

HealthtechMedical Devices

Founders & leadership

MBMatt Brokaw
Matt BrokawinCEO & President
DS
Derrick SunginChief Financial Officer2023–2025
MSMatthew Salkeld
Matthew SalkeldExecutive
IRIrina Ridley
Irina RidleyinChief Legal OfficerIrina Ridley is Chief Legal Officer at Aerin Medical, a medical device company developing radiofrequency treatment systems for nasal conditions. Previously, she served as Chief Legal Officer and Head of Investor Relations at NeuroPace, Inc., which she helped guide through its initial public offering.
ACAndre Cheng
Andre ChenginChief Financial Officer & Chief Strategy Officer
FDFred Dinger
Fred DingerinExecutive
SWScott Wolf
Scott WolfinFounderScott Wolf is a founder of multiple medical device companies, including Aerin Medical, Volt Health, Zeltiq, Primaeva, Endogastric Solutions, and Cardiac Dimensions.

Board

GG
Gregory GarfieldBoard director
KRKevin Reilly
Kevin ReillyinBoard MemberManaging Director and Head of MedTech Investments at Ally Bridge Group
KL
Karen LongBoard director
RDRyan Drant
Ryan Drantin𝕏Board directorFounder and Managing Partner at Questa Capital
NK
Nael KassarBoard director

Investors · 6

LaunchCapitalBranford · $50K – $150K
OrbiMedNew York · $1M – $75M
Questa CapitalSan Francisco · $15M – $40Mvia Ryan Drant · board
Targeted Technology FundsSan Antoniovia Alan Dean · inferred
Ally Bridge GroupreportedNew York
HorizonreportedMiami Beach

Reported raises · per SEC filings

Form D private placements

$144.9M disclosed across 7 rounds · 2014–2024

▶$32.5MraisedDec 2024 · 23 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Gregory GarfieldDirector
  • Derrick SungExecutive Officer
  • Matthew BrokawExecutive Officer, Director
  • David ThrowerDirector
  • Matthew SalkeldExecutive Officer
  • Irina RidleyExecutive Officer
  • Kevin ReillyDirector
  • Andre ChengExecutive Officer
  • Karen LongDirector
  • William FacteauDirector
  • Ryan DrantDirector
  • Nael KassarDirector
  • Scott WolfExecutive Officer
Offering amount
$32.8M
Amount sold
$32.5M
First sale
Dec 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$34.9MraisedMay 2022 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Bill McClellanExecutive Officer
  • John WhiteDirector
  • Fred DingerExecutive Officer
  • David ThrowerDirector
  • William FacteauDirector
  • Scott WolfExecutive Officer
  • Matthew BrokawExecutive Officer, Director
  • Ryan DrantDirector
  • Kevin ReillyDirector
  • Karen LongDirector
  • Gregory GarfieldDirector
Offering amount
$60M
Amount sold
$34.9M
First sale
Apr 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$49.7MraisedAug 2020 · 15 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Karen LongDirector
  • William FacteauDirector
  • Matthew BrokawExecutive Officer, Director
  • Valeska SchroederDirector
  • Scott WolfExecutive Officer, Director
  • Fred DingerExecutive Officer
  • Bill McClellanExecutive Officer
  • David ThrowerDirector
Offering amount
$49.7M
Amount sold
$49.7M
First sale
Aug 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10MraisedDec 2017 · 16 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Gregory GarfieldDirector
  • Fred DingerExecutive Officer, Director
  • Valeska SchroederDirector
  • Scott WolfExecutive Officer, Director
  • Kern BhugraDirector
Offering amount
$15M
Amount sold
$10M
Minimum investment
$1
First sale
Dec 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10.6MraisedMar 2016 · 3 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Fred DingerExecutive Officer, Director
  • Kern BhugraDirector
  • Gregory S. YoungDirector
  • Nael KassarDirector
  • Peter SavasDirector
  • Scott WolfExecutive Officer, Director
  • Greg GarfieldDirector
Offering amount
$10.6M
Amount sold
$10.6M
Minimum investment
$1
First sale
Mar 2016
Incorporated
Corporation, Delaware, 2011
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.7MraisedOct 2015 · 11 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Gregory GarfieldDirector
  • Greg YoungDirector
  • Kern BhugraDirector
  • Fred DingerExecutive Officer, Director
  • Scott WolfExecutive Officer, Director
  • Peter SavasDirector
Offering amount
$14.4M
Amount sold
$6.7M
Minimum investment
$1
Sales commissions
$7.9K
Placement agents
Braymen Lambert & Noel Securities, Ltd.
First sale
Jul 2015
Incorporated
Corporation, Delaware, 2011
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$525KraisedFeb 2014 · 4 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Greg GarfieldDirector
  • Kern BhugraDirector
  • Scott WolfExecutive Officer, Director
Offering amount
$2.5M
Amount sold
$525K
Minimum investment
$1
First sale
Feb 2014
Incorporated
Corporation, Delaware, 2011
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
Rf Surgical23 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.

Companies competing with Aerin Medical for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Aerin Secures New Funding to Further its Growth - Medical Product Outsourcingmpo-mag.com · Feb 2025Aerin Medical raises $16.7m Series C investmentdealstreetasia.com · Mar 2016

Frequently asked questions

What does Aerin Medical do?
Aerin Medical develops non-invasive radiofrequency treatment systems for chronic nasal conditions, offering the VivAer stylus for nasal airway obstruction and RhinAer stylus for chronic rhinitis. The treatments are performed in doctor's offices and operating rooms using a touch-screen console that delivers temperature-controlled radiofrequency therapy.
Who are Aerin Medical's investors?
Aerin Medical's investors include LaunchCapital, OrbiMed, Questa Capital, Targeted Technology Funds, Ally Bridge Group, Horizon.
How much funding has Aerin Medical raised?
Aerin Medical has disclosed $144.9M raised across 7 rounds.
Where is Aerin Medical headquartered?
Aerin Medical is headquartered in Mountain View, US.